Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Phenylketonuria (PKU) is a genetically determined metabolic disorder that is highly treatable with diet and supplements. It is an inherited disease in which the body cannot metabolize an amino acid called phenylalanine. Normally phenylalanine is metabolized and converted into tyrosine, another amino acid, but if it stays as phenylalanine, there will be too much of it, and high levels of phenylalanine are harmful to the brain. Following the prescribed diet for PKU is a lifelong endeavor that requires a lot of support from family and your health care provider. If your child is able to strictly follow the diet and supplement regimen, he should be able to live a full, active life.
How Boston Children’s Hospital approaches PKU
The Metabolism Program at Boston Children’s Hospital, part of the Division of Genetics, takes a comprehensive, multidisciplinary approach to testing for and treating children with PKU. Our dedicated team of physicians, nutritionists, nurses, laboratory technicians, social workers and psychologists are committed to helping children with this highly treatable condition. PKU requires life-long care, and our multidisciplinary team will work with you and your child to help him grow into a healthy adult.
Phenylketonuria: Reviewed by Harvey Levy, MD
© Boston Children’s Hospital, 2012
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”